Your email has been successfully added to our mailing list.

×
-0.179856115107914 -0.179856115107914 -0.343165467625899 -0.343165467625899 -0.343165467625899 -0.287769784172662 -0.287769784172662 -0.287769784172662
Stock impact report

NeuroVive Pharmaceutical AB Year End Report January - December 2019

ABLIVA AB (NEVPF) 
NASDAQ:AMEX Investor Relations: neurovive.com/investor
Company Research Source: PR Newswire
STOCKHOLM, Feb. 19, 2020 /PRNewswire/ --Important events in 2019KL1333            NeuroVive enrolls first subject in its European KL1333 phase Ia/b clinical study            NeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study            NeuroVive completes recruitment of healthy volunteers in the second part of its ongoing KL1333 clinical Phase Ia/b studyNV354            NeuroVive initiates NV354 preclinical safety studies and scales up compound productionNeuroSTAT            NeuroVive's IND for clinical development of NeuroSTAT approved by FDA            NeuroSTAT receives Fast Track designation from the US Food and Drug AdministrationFinancials            NeuroVive is supplied with approximately MSEK 99.0 in share issue proceeds            NeuroVive receives SEK 28.2 Million in a directed new share issueStrategy and communications            NeuroVive updates its strategy and sharpens its focus on primary mitochondrial diseases            NeuroVive hosts Show less Read more
Impact Snapshot
Event Time:
NEVPF
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for NEVPF alerts
Opt-in for
NEVPF alerts

from News Quantified
Opt-in for
NEVPF alerts

from News Quantified